×
Bayer Receivables 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bayer receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
View More
Bayer Receivables 2010-2024 | BAYRY
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Bayer receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
Related Stocks
Company Name
Market
Cap
Eli Lilly (LLY)
$710.1B
Novo Nordisk (NVO)
$471.5B
Johnson & Johnson (JNJ)
$373.6B
AbbVie (ABBV)
$312.7B
Merck (MRK)
$250.9B
Novartis AG (NVS)
$213.1B
AstraZeneca (AZN)
$203.5B
Pfizer (PFE)
$145.4B
Sanofi (SNY)
$122.5B
Innoviva (INVA)
$1.2B